Cholesterol-Lowering Drugs And Alzheimer’S Disease-Reference-Cited by-同舟云学术

Cholesterol-Lowering Drugs And Alzheimer’S Disease

Published:2007-08-01 Issue:4 Volume:2 Page:423-432
ISSN:1746-0875
Container-title:Future Lipidology
language:en
Short-container-title:Future Lipidology

Author:

Eckert Gunter P¹,Müller Walter E¹,Wood Gibson W.²

Affiliation:

1. University of Frankfurt, Department of Pharmacology, Biocenter Niederursel, Mari-Curie-Str. 9, Frankfurt, D-60439, Germany Tex.: , Fax.: ,

2. University of Minnesota School of Medicine and Geriatric Research, Department of Pharmacology, Education and Clinical Center, VA Medical Center, Minneapolis, MN 55417, USA Tex.: , Fax.: ,

Publisher

Informa UK Limited

Subject

Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.2217/17460875.2.4.423

Reference94 articles.

1. Hamelin BA, Turgeon J: Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol. Sci. 19, 26–37 (1998).

2. Lousberg TR, Denham AM, Rasmussen JR: A comparison of clinical outcome studies among cholesterol-lowering agents. Ann. Pharmacother. 35(12), 1599–1607 (2001).

3. Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F: New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol. Ther. 84(3), 413–428 (1999).

4. Good overview of the pharmacodynamics and pharmokinetics of statins.

5. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F: Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc. Natl Acad. Sci. USA 98(10), 5815–5820 (2001).

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathology;Future Science OA;2023-10-04

2. Clinical Biomarkers and Novel Drug Targets to Cut Gordian Knots of Alzheimer's Disease;Current Molecular Pharmacology;2023-06

3. Dose-dependent effects of simvastatin, atorvastatin and rosuvastatin on apoptosis and inflammation pathways on cancerous lung cells;Ankara Üniversitesi Veteriner Fakültesi Dergisi;2022-01-27

4. Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go;ACS Pharmacology & Translational Science;2021-01-27

5. Alzheimer’s Disease Today;Bursting Neurons and Fading Memories;2015